Lens on new pharmacy colleges in Maharashtra over complaints about forged maps, NOCs, occupancy certificates for approvals
More than 115 colleges offering B Pharm and nearly 200 offering D Pharm have emerged during this period.
Acting on these complaints, state govt has ordered a re-inspection of all such institutions to verify the authenticity of their documents and whether they meet all the requirements. The aim is to contain the mushrooming of colleges in the state and prevent vacancies of seats during admissions. Data from the Directorate of Technical Education (DTE) shows that over 30% of seats remained vacant last year in both B Pharm and D Pharm courses in the state.
In a recent order, govt stated that several complaints were received by the higher and technical education minister regarding pharmacy, diploma, degree, and postgraduate institutions that were granted approval by submitting bogus documents such as certified maps, no-objection certificates (NOCs), occupancy certificates, and utility certificates to state and central govts. The order directed: "The validity of these documents should be verified with the relevant authorities, and an institution-wise inspection report should be submitted to confirm whether adequate educational facilities are available.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Novi ortopedski sandali za moške poletje 2025.
Fiippy
KUPITE ZDAJ
Undo
" The Pharmacy Council of India (PCI) gives approval to new institutions once affiliating universities and respective state govts provide them with NOCs.
Milind Umekar, president of the Indian Pharmaceutical Congress Association, a federation of five pharmaceutical associations, highlighted two key reasons behind the rapid increase in pharmacy institutions in Maharashtra. "The demand for pharmacy courses surged after the Covid-19 pandemic, as people began recognising growing opportunities in the pharmaceutical industry, including research, clinical studies, pharmacovigilance, formulation and development, and drug or vaccine manufacturing.
India ranks third globally in drug production by volume and is among the top exporters. Secondly, before 2022, the PCI imposed a moratorium on setting up new institutes. Once this was lifted following a court order, several colleges rushed to introduce pharmacy programmes," he said, adding that a comprehensive re-inspection exercise is crucial to ensure all institutions meet PCI norms, including the required number of qualified faculty, infrastructure, and laboratories.
A representative from a college management said that in the last three years, many colleges were given NOCs by the respective universities, mainly Dr Babasaheb Ambedkar Technological University (BATU) Lonere, without any physical inspection and based on documents submitted by the institutions. "BATU has the highest number of affiliated pharmacy colleges in the state, and most may have come up in the last three years.
The university, set up exclusively for technical colleges in the state, faces a severe shortage of manpower, impacting the quality of education in the affiliated institutions," he alleged.
A govt official said that officials from the Maharashtra State Board of Technical Education and DTE have started carrying out the inspection exercise, adding that no timeline has been provided.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
33 minutes ago
- Business Standard
Piyush Goyal seeks apology from CM Siddaramaiah over remarks on vaccine
Union Minister Piyush Goyal on Saturday demanded that Karnataka Chief Minister Siddaramaiah apologise to the country's scientists and pharmaceutical sector for his recent remarks linking COVID-19 vaccines to a spate of heart attack deaths in the state and questioned whether he was "running the agenda of foreign forces". Accusing the Chief Minister of "insulting" India's scientists, startups, and its pharmaceutical strength, Goyal said his comments undermine the people who worked tirelessly during the pandemic. According to Goyal, it is "unfortunate" that such remarks are coming from the CM of a country that is known as the 'pharmacy of the world', a country where our startups are expanding and forming an ecosystem, a country where our vaccines were exported on a large scale to other nations. This was possible only because our pharmaceutical companies had the strength and innovation to produce vaccines at a cost of less than Rs 100, he told reporters here. Lauding the pharmaceutical companies, he said they made India proud. "We didn't just roll out one vaccine, but two. The country was able to provide free vaccines to our entire population... He insulted our scientists and pharmaceutical companies," he claimed. "Is he running the agenda of foreign forces that want to harm India's pharmaceutical sector, disturbed by India's financial growth? Whether it is the Congress party, the CM, or all their partners, do they want to strengthen the hands of foreign forces by demeaning India? He should answer and apologise to our scientists and pharmaceutical companies," he further alleged. Earlier, addressing the IIT Madras Alumni Association's Sangam 2025 event here, he added that Siddaramaiah does not take pride in India's success or its startups and scientists. Instead, he is "ashamed of India and its startups achieving such remarkable success." He credited Bharat Biotech for developing India's first indigenous COVID-19 vaccine, Covaxin, and Oxford-AstraZeneca for granting rights to produce Covishield at Pune-based Serum Institute of India. "We were not only able to provide 2.5 billion vaccines free of charge to all our citizens, but also supplied vaccines to over 100 nations, particularly less developed or developing countries that otherwise had no protection against this disease," he said. Goyal pointed out that even today, India is being thanked for the medicines and vaccines it provided to other nations during the pandemic. "They (Congress) want to run down India's success stories, and it pains us when we hear this kind of negativity coming from certain sections of society," he alleged. Neither the Congress nor Siddaramaiah has responded to Goyal's claims so far.
Time of India
an hour ago
- Time of India
DRDO, AIIMS-Rishikesh ink MoU for clinical trials in field of biomedical devices
An institute of the DRDO has signed an agreement with AIIMS, Rishikesh for conducting " clinical trials " and advanced research in the field of biomedical devices related to human performance in extreme environments. The collaboration between the Defence Research and Development Organisation (DRDO) and the All India Institute of Medical Sciences (AIIMS) will facilitate the development of products, technologies and strategies for the "mitigation of effects" of extreme environments on human performance, officials said. Defence Institute of Physiology and Allied Sciences (DIPAS) of the DRDO has signed an MoU with AIIMS, Rishikesh for "conducting clinical trials and advanced research in the field of biomedical devices and supplements related to human performance in extreme environments," a senior official said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Undo This collaborative effort will facilitate the formulation and development of products, technologies and strategies for mitigation of effects of extreme environment on human performance, they said. The DRDO also shared some photos of the Memorandum of Understanding (MoU) signing in a post on X late Friday.
Indian Express
an hour ago
- Indian Express
‘Siddaramaiah must clarify whether he is weakening India to serve external interests': Minister Piyush Goyal slams Karnataka CM over vaccine remarks
Union Commerce and Industry Minister Piyush Goyal Saturday lashed out at Karnataka Chief Minister Siddaramaiah, accusing him and the Congress of belittling India's scientific community and pharmaceutical sector. Goyal's rebuttal came in response to Siddaramaiah's recent remarks suggesting a possible link between Covid-19 vaccines and the rising incidence of heart attacks in Hassan district. Defending India's vaccination drive, Goyal, speaking to reporters in Bengaluru, said, 'India, with its vast population, successfully provided 250 crore vaccine doses free of cost because of our companies' ability to manufacture vaccines for less than Rs 100 per dose. But here we have a chief minister who seems to be insulting and undermining them. When they demean our scientists and the pharmaceutical industry, it raises questions about their motives. Are they acting at the behest of foreign powers? Are these powers uncomfortable with India's progress and trying to harm our pharmaceutical sector?' Goyal alleged that Siddaramaiah's remarks appeared to serve the interests of those opposed to India's economic growth. 'The Congress party, along with their chief minister, must clarify whether they are weakening India to serve external interests. They must apologise to our scientists and the pharmaceutical industry,' he said. The row erupted after Siddaramaiah, in a post on X on July 1, linked the recent spike in heart attack deaths in Hassan district to Covid-19 vaccines. Citing reports of over 20 heart attack-related deaths in the district in a month, Siddaramaiah wrote, 'It cannot be denied that the hasty approval and distribution of the Covid vaccine to the public could also be a reason for these deaths, as several studies worldwide have recently indicated that COVID vaccines could be a cause for the increasing number of heart attacks.' The chief minister announced the formation of an expert committee led by Dr K S Ravindranath, senior cardiologist and former director of the Jayadeva Institute of Cardiovascular Sciences and Research, to investigate the deaths. However, the committee in its study found no direct causal association between Covid-19 vaccination or prior Covid-19 infection and premature cardiovascular disease. In fact, most global studies reviewed in the report confirmed that vaccination is protective against long-term cardiac risks. The report attributes the rise in sudden cardiac events to a combination of factors including lifestyle changes during the pandemic (poor diet, reduced physical activity, stress, etc); higher prevalence of cardiometabolic risk factors (diabetes, hypertension, obesity); genetic predisposition, recreational drug use, and binge drinking and vigorous physical activity shortly before death in some cases. The report emphasises that 'long Covid' is unlikely to be the driver behind the current rise in sudden cardiac deaths. It points instead to common, modifiable risk factors as the dominant contributors. Siddaramaiah's comments had triggered widespread criticism from health experts, industry leaders like Biocon's Kiran Mazumdar-Shaw, and the Union Health Ministry, which warned against spreading vaccine hesitancy. Amid the backlash, Siddaramaiah clarified his stand on July 3, reiterating that his statement stemmed from empathy towards grieving families and not from anti-vaccine sentiments. He said, 'When parents lose young children or families lose breadwinners suddenly, demanding answers is not misinformation – it is governance rooted in empathy.' He also acknowledged the crucial role played by Covid-19 vaccines in saving lives but cited global studies and even admissions by some vaccine makers, including AstraZeneca, regarding rare side effects like myocarditis. He further explained that his reference to 'hasty' approvals was about the emergency nature of vaccine rollouts worldwide, which were taken with limited long-term data – a 'calculated risk' acknowledged by the World Health Organization itself. 'Scientific caution is not anti-science,' he said, emphasising that transparency in governance also includes acknowledging rare risks. Meanwhile, Goyal also took a swipe at the Congress-led UPA government's record on trade agreements. He asserted that India now negotiates from a position of strength, with national interest as its top priority. 'Since the Modi government took charge, India has signed free trade agreements with Mauritius, the UAE, Australia, the EFTA group (Switzerland, Norway, Iceland, Liechtenstein), and the UK,' Goyal said. He noted that negotiations are underway with the EU, the US, Oman, Peru, and Chile. 'This is not the weak India of the Congress-UPA era, which signed deals compromising our national interests. Today, India negotiates confidently and competes globally,' he remarked.
